Forum Markets, Inc. (FRMM)
6.03
+0.55
(+10.04%)
USD |
NASDAQ |
Aug 24, 16:00
6.00
-0.03
(-0.50%)
After-Hours: 20:00
Forum Markets Shareholders Equity (Quarterly) : 127.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.80M |
| March 31, 2026 | 168.34M |
| December 31, 2025 | 239.42M |
| September 30, 2025 | 445.14M |
| June 30, 2025 | 5.381M |
| March 31, 2025 | 7.706M |
| December 31, 2024 | 9.252M |
| September 30, 2024 | 3.734M |
| June 30, 2024 | -0.418M |
| March 31, 2024 | -0.9545M |
| December 31, 2023 | -0.1277M |
| September 30, 2023 | -0.1493M |
| June 30, 2023 | 6.716M |
| March 31, 2023 | 7.140M |
| December 31, 2022 | 11.34M |
| September 30, 2022 | 26.08M |
| Date | Value |
|---|---|
| June 30, 2022 | 42.79M |
| March 31, 2022 | 40.90M |
| December 31, 2021 | 39.32M |
| September 30, 2021 | 37.14M |
| June 30, 2021 | 2.716M |
| March 31, 2021 | 22.71M |
| December 31, 2020 | |
| September 30, 2020 | 4.748M |
| June 30, 2020 | 8.484M |
| March 31, 2020 | 5.130M |
| December 31, 2019 | 5.347M |
| September 30, 2019 | 44.76M |
| June 30, 2019 | 44.78M |
| March 31, 2019 | 61.27M |
| December 31, 2018 | 113.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 128.06M |
| Corcept Therapeutics, Inc. | 705.78M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.03M |
| Total Liabilities (Quarterly) | 31.23M |
| Debt to Equity Ratio | 0.203 |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -7.19% |